[HTML][HTML] 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
[HTML][HTML] Adherence to the 'atrial fibrillation better care'pathway in patients with atrial fibrillation: impact on clinical outcomes—a systematic review and meta-analysis of …
Objective The 'Atrial fibrillation Better Care'(ABC) pathway has been recently proposed as a
holistic approach for the comprehensive management of patients with atrial fibrillation (AF) …
holistic approach for the comprehensive management of patients with atrial fibrillation (AF) …
Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated …
M Yoon, PS Yang, E Jang, HT Yu… - Thrombosis and …, 2019 - thieme-connect.com
Background An integrated care approach might be of benefit for clinical outcomes of patients
with atrial fibrillation (AF). This study evaluated whether compliance with the Atrial fibrillation …
with atrial fibrillation (AF). This study evaluated whether compliance with the Atrial fibrillation …
Atrial fibrillation and stroke
SE Choi, D Sagris, A Hill, GYH Lip… - Expert Review of …, 2023 - Taylor & Francis
Introduction Stroke is one of the leading causes of mortality and morbidity globally. Atrial
fibrillation (AF) is the most common sustained cardiac arrhythmia. It is set to reach epidemic …
fibrillation (AF) is the most common sustained cardiac arrhythmia. It is set to reach epidemic …
[HTML][HTML] Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert …
While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …
[HTML][HTML] Cardiovascular research using the Korean national health information database
EK Choi - Korean circulation journal, 2020 - synapse.koreamed.org
Abstract The Korean National Health Information Database (NHID) contains nationwide
claims data, including sociodemographic data, health care utilization, health screening data …
claims data, including sociodemographic data, health care utilization, health screening data …
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
Direct oral anticoagulants in patients with atrial fibrillation and liver disease
Background: Advanced liver disease is known to increase the risk for bleeding and affects
the hepatic clearance and metabolism of drugs. Subjects with active liver disease were …
the hepatic clearance and metabolism of drugs. Subjects with active liver disease were …
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy
M Coppens, JW Eikelboom, RG Hart… - European heart …, 2013 - academic.oup.com
Abstract Aims The CHA2DS2-VASc score is a modification of the CHADS2 score that aims to
improve stroke risk prediction in patients with atrial fibrillation (AF) by adding three risk …
improve stroke risk prediction in patients with atrial fibrillation (AF) by adding three risk …
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in …
Whilst there is a clear clinical benefit of oral anticoagulation (OAC) in patients with atrial
fibrillation (AF) and venous thromboembolism (VTE) in reducing the risks of …
fibrillation (AF) and venous thromboembolism (VTE) in reducing the risks of …